BACKGROUND: Heart failure is a growing epidemic, and a typical aspect of heart failure pathophysiology is altered calcium transients. Normal cardiac calcium transients are initiated by Cav1.2 channels at cardiac T tubules. Bridging integrator 1 (BIN1) is a membrane scaffolding protein that causes Cav1.2 to traffic to T tubules in healthy hearts. The mechanisms of Cav1.2 trafficking in heart failure are not known. OBJECTIVE: To study BIN1 expression and its effect on Cav1.2 trafficking in failing hearts. METHODS: Intact myocardium and freshly isolated cardiomyocytes from nonfailing and end-stage failing human hearts were used to study BIN1 expression and Cav1.2 localization. To confirm Cav1.2 surface expression dependence on BIN1, patch-clamp recordings were performed of Cav1.2 current in cell lines with and without trafficking-competent BIN1. Also, in adult mouse cardiomyocytes, surface Cav1.2 and calcium transients were studied after small hairpin RNA-mediated knockdown of BIN1. For a functional readout in intact heart, calcium transients and cardiac contractility were analyzed in a zebrafish model with morpholino-mediated knockdown of BIN1. RESULTS: BIN1 expression is significantly decreased in failing cardiomyocytes at both mRNA (30% down) and protein (36% down) levels. Peripheral Cav1.2 is reduced to 42% by imaging, and a biochemical T-tubule fraction of Cav1.2 is reduced to 68%. The total calcium current is reduced to 41% in a cell line expressing a nontrafficking BIN1 mutant. In mouse cardiomyocytes, BIN1 knockdown decreases surface Cav1.2 and impairs calcium transients. In zebrafish hearts, BIN1 knockdown causes a 75% reduction in calcium transients and severe ventricular contractile dysfunction. CONCLUSIONS: The data indicate that BIN1 is significantly reduced in human heart failure, and this reduction impairs Cav1.2 trafficking, calcium transients, and contractility.
BACKGROUND:Heart failure is a growing epidemic, and a typical aspect of heart failure pathophysiology is altered calcium transients. Normal cardiac calcium transients are initiated by Cav1.2 channels at cardiac T tubules. Bridging integrator 1 (BIN1) is a membrane scaffolding protein that causes Cav1.2 to traffic to T tubules in healthy hearts. The mechanisms of Cav1.2 trafficking in heart failure are not known. OBJECTIVE: To study BIN1 expression and its effect on Cav1.2 trafficking in failing hearts. METHODS: Intact myocardium and freshly isolated cardiomyocytes from nonfailing and end-stage failing human hearts were used to study BIN1 expression and Cav1.2 localization. To confirm Cav1.2 surface expression dependence on BIN1, patch-clamp recordings were performed of Cav1.2 current in cell lines with and without trafficking-competent BIN1. Also, in adult mouse cardiomyocytes, surface Cav1.2 and calcium transients were studied after small hairpin RNA-mediated knockdown of BIN1. For a functional readout in intact heart, calcium transients and cardiac contractility were analyzed in a zebrafish model with morpholino-mediated knockdown of BIN1. RESULTS:BIN1 expression is significantly decreased in failing cardiomyocytes at both mRNA (30% down) and protein (36% down) levels. Peripheral Cav1.2 is reduced to 42% by imaging, and a biochemical T-tubule fraction of Cav1.2 is reduced to 68%. The total calcium current is reduced to 41% in a cell line expressing a nontrafficking BIN1 mutant. In mouse cardiomyocytes, BIN1 knockdown decreases surface Cav1.2 and impairs calcium transients. In zebrafish hearts, BIN1 knockdown causes a 75% reduction in calcium transients and severe ventricular contractile dysfunction. CONCLUSIONS: The data indicate that BIN1 is significantly reduced in humanheart failure, and this reduction impairs Cav1.2 trafficking, calcium transients, and contractility.
Authors: F Schröder; R Handrock; D J Beuckelmann; S Hirt; R Hullin; L Priebe; R H Schwinger; J Weil; S Herzig Journal: Circulation Date: 1998-09-08 Impact factor: 29.690
Authors: Xiongwen Chen; Valentino Piacentino; Satoshi Furukawa; Bruce Goldman; Kenneth B Margulies; Steven R Houser Journal: Circ Res Date: 2002-09-20 Impact factor: 17.367
Authors: Peter J Mohler; Jean-Jacques Schott; Anthony O Gramolini; Keith W Dilly; Silvia Guatimosim; William H duBell; Long-Sheng Song; Karine Haurogné; Florence Kyndt; Mervat E Ali; Terry B Rogers; W J Lederer; Denis Escande; Herve Le Marec; Vann Bennett Journal: Nature Date: 2003-02-06 Impact factor: 49.962
Authors: Alexander J Muller; Judith F Baker; James B DuHadaway; Kai Ge; George Farmer; P Scott Donover; Raymond Meade; Christian Reid; Reinhard Grzanna; Arthur H Roach; Neelima Shah; Alejandro Peralta Soler; George C Prendergast Journal: Mol Cell Biol Date: 2003-06 Impact factor: 4.272
Authors: Eunkyung Lee; Melissa Marcucci; Laurie Daniell; Marc Pypaert; Ora A Weisz; Gian-Carlo Ochoa; Khashayar Farsad; Markus R Wenk; Pietro De Camilli Journal: Science Date: 2002-08-16 Impact factor: 47.728
Authors: Ting-Ting Hong; Rebecca Cogswell; Cynthia A James; Guson Kang; Clive R Pullinger; Mary J Malloy; John P Kane; Julianne Wojciak; Hugh Calkins; Melvin M Scheinman; Zian H Tseng; Peter Ganz; Teresa De Marco; Daniel P Judge; Robin M Shaw Journal: Heart Rhythm Date: 2012-01-31 Impact factor: 6.343
Authors: Ye Chen-Izu; Robin M Shaw; Geoffrey S Pitt; Vladimir Yarov-Yarovoy; Jon T Sack; Hugues Abriel; Richard W Aldrich; Luiz Belardinelli; Mark B Cannell; William A Catterall; Walter J Chazin; Nipavan Chiamvimonvat; Isabelle Deschenes; Eleonora Grandi; Thomas J Hund; Leighton T Izu; Lars S Maier; Victor A Maltsev; Celine Marionneau; Peter J Mohler; Sridharan Rajamani; Randall L Rasmusson; Eric A Sobie; Colleen E Clancy; Donald M Bers Journal: J Physiol Date: 2015-03-15 Impact factor: 5.182